Cash & equivalents increased 43.5%
Cash & equivalents changed +43.5% from the comparable as-filed period.
$397.5M→$570.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →INVA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 714 bp lower
Gross margin changed -714 basis points from the comparable as-filed period.
82.91%→75.77%1 prior comparisons
Inventory decreased 20.5%
Inventory changed -20.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$49.0M→$39.0M4 prior comparisons
Net income decreased 231.0%
Net income changed -231.0% from the comparable as-filed period.
$63.7M→-$83.4M2 prior comparisons
Operating margin moved 609 bp lower
Operating margin changed -609 basis points from the comparable as-filed period.
48.61%→42.52%1 prior comparisons
Research & development decreased 35.0%
Research & development changed -35.0% from the comparable as-filed period.
$8.0M→$5.2M3 prior comparisons
Revenue increased 19.3%
Revenue changed +19.3% from the comparable as-filed period.
$100.3M→$119.6M3 prior comparisons
Selling, general & administrative increased 30.9%
Selling, general & administrative changed +30.9% from the comparable as-filed period.
$26.4M→$34.6M3 prior comparisons
Stock-based compensation increased 95.8%
Stock-based compensation changed +95.8% from the comparable as-filed period.
$2.4M→$4.7M3 prior comparisons
Gross profit increased 9.0%
Gross profit changed +9.0% from the comparable as-filed period.
$83.1M→$90.6M1 prior comparisons
Operating income increased 4.3%
Operating income changed +4.3% from the comparable as-filed period.
$48.8M→$50.9M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.